Onkos Surgical Gains FDA Clearance for ELEOS™ Proximal Tibia with NanoCept® Technology
Parsippany, N.J., October 21, 2025: Onkos Surgical®, a leader in complex orthopaedic innovation, has received U.S. FDA 510(k) clearance...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Parsippany, N.J., October 21, 2025: Onkos Surgical®, a leader in complex orthopaedic innovation, has received U.S. FDA 510(k) clearance...
